Antibacterial envelope use to prevent cardiac implantable device infection: outcomes from the national readmission database

Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device Infection undergoing transvenous lead extraction: the impact of the Infection type and the presence of vegetation on survival. Europace Oct. 2014;16:1490–5.

Article  Google Scholar 

Dai M, Cai C, Vaibhav V, et al. Trends of Cardiovascular Implantable Electronic Device Infection in 3 decades: a Population-based study. JACC Clin Electrophysiol Sep. 2019;5:1071–80.

Article  Google Scholar 

Krahn AD, Longtin Y, Philippon F, et al. Prevention of Arrhythmia device Infection trial: the PADIT Trial. J Am Coll Cardiol Dec. 2018;18:72:3098–109.

Article  Google Scholar 

Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial envelope to prevent Cardiac Implantable device Infection. N Engl J Med May. 2019;16:380:1895–905.

Article  Google Scholar 

Prutkin JM, Reynolds MR, Bao H, et al. Rates of and factors associated with Infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation Sep. 2014;23:130:1037–43.

Article  Google Scholar 

Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the Infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol Aug. 2011;30:58:1001–6.

Article  Google Scholar 

留言 (0)

沒有登入
gif